A Retrospective Chart Review to Evaluate Diagnosis and Treatment of Chronic Migraine and Headache

Allergan

Status: Completed

Conditions: Migraine Disorders; Headache

Treatments: Other: No Intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT01946126

GMA-BTX-CM-13-592

Details and patient eligibility

About

This study is a retrospective chart review in patients diagnosed with headache or migraine to evaluate treatment patterns and diagnosis.

Enrollment: 459 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of chronic migraine or other diagnosis of migraine or headache for a minimum of 15 months
• Eight (8) headache days per month for at least 1 of the preceding 15 months

Exclusion criteria

• Not currently diagnosed with chronic migraine, headache or migraine
• History of receiving botulinum toxin injections for the treatment of chronic migraine.

Trial design

459 participants in 2 patient groups

Chronic Migraine Diagnosis

Description:

This is a retrospective chart review for patients diagnosed with Chronic Migraine. There is no intervention in this study.

Treatment:

Other: No Intervention

Other Headache Diagnoses

Description:

This is a retrospective chart review of patients with headache diagnoses other than Chronic Migraine. There is no intervention in this study.

Treatment:

Other: No Intervention